Hepatitis B Clinical Trials

A listing of Hepatitis B medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 326 clinical trials
Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.

This study is to investigate the clinical efficacy and safety of Nucleoside (acid) analogues treatment in patients with normal Alanine Aminotransferase and positive Hepatitis B virus DNA

  • 0 views
  • 30 Apr, 2021
  • 1 location
A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

pre-emptive use of lamivudine, one can drastically reduce liver-related morbidity and mortality in such patients. However, due to the development of hepatitis B virus resistance to

adefovir
hepatitis
hepatitis b antigen
liver disease
lamivudine
  • 8 views
  • 07 Nov, 2020
  • 1 location
HBV Vaccine in Anti-core Positive Donors After LT

Anti-HBc positive liver donors frequently have occult HBV infection, and several studies in HBsAg-negative subjects have shown that there is often the detection in the liver of covalently closed

  • 0 views
  • 24 Jan, 2021
TAF to Prevent HBV Reactivation in Cancer Patients

Tenofovir alafenamide (TAF) has been approved to prevent HBV reactivation for HBsAg-positive cancer patients receiving chemotherapy. However, the real-world effectiveness and safety of TAF for

  • 0 views
  • 11 Jul, 2021
  • 5 locations
Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:

The objective of this study is to identify immunological mechanisms that contribute to normalization of liver inflammation in chronic hepatitis B (CHB) patients starting the antiviral nucleoside

  • 0 views
  • 23 Jan, 2021
  • 1 location
A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine

The purpose of this study is to evaluate the evaluate and safety of the investigational medicinal product CVI-HBV-002.

fumarate
antiviral drugs
hepatitis b antigen
chronic hepatitis
tenofovir
  • 5 views
  • 24 Jan, 2021
  • 9 locations
Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B

Although the best treatment choice for chronic hepatitis B is not clarified yet, certain therapeutic concepts could be derived from the experience of treating patients with chronic

hepatitis b e antigen
hepatitis d
serum antibody
entecavir
liver disease
  • 21 views
  • 07 Nov, 2020
Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients

A multiple-center, open-label, Phase II clinical trial to evaluate the safety and the efficacy of HLX10 in chronic hepatitis B patients.

hepatitis b antigen
neutrophil count
chronic hepatitis
  • 2 views
  • 25 Jan, 2021
  • 3 locations
  • 0 views
  • 29 Jun, 2021
  • 1 location
Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides

Both tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) are potent antiviral agents for hepatitis B virus (HBV) and recommended by the American Association for the Study of

adefovir
antiviral drugs
tenofovir alafenamide 25 mg
entecavir
liver disease
  • 0 views
  • 26 Jan, 2021
  • 10 locations